Alzamend Neuro (ALZN) Short Interest Ratio & Short Volume $1.10 +0.10 (+10.00%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$1.06 -0.04 (-3.18%) As of 03/27/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alzamend Neuro Short Interest DataAlzamend Neuro (ALZN) has a short interest of 120,900 shares, representing 1.91% of the float (the number of shares available for trading by the public). This marks a -47.02% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 566,887 shares to cover all short positions.Current Short Interest120,900 sharesPrevious Short Interest228,200 sharesChange Vs. Previous Month-47.02%Dollar Volume Sold Short$81,873.48Short Interest Ratio0.3 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares6,597,000 sharesFloat Size6,320,000 sharesShort Percent of Float1.91%Today's Trading Volume180,504 sharesAverage Trading Volume566,887 sharesToday's Volume Vs. Average32% Short Selling Alzamend Neuro? Sign up to receive the latest short interest report for Alzamend Neuro and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALZN Short Interest Over TimeALZN Days to Cover Over TimeALZN Percentage of Float Shorted Over Time Remove Ads Alzamend Neuro Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2025120,900 shares $81,873.48 -47.0%1.9%0.3 $0.68 2/28/2025228,200 shares $187,124.00 +332.2%4.4%0.6 $0.82 2/15/202552,800 shares $57,552.00 -33.0%1.0%0.1 $1.09 1/31/202578,800 shares $89,438.00 +6.1%1.5%0.6 $1.14 1/15/202574,300 shares $86,931.00 +130.8%1.4%0.5 $1.17 12/31/202432,200 shares $37,352.00 -48.8%0.6%0.2 $1.16 12/15/202462,900 shares $74,851.00 -52.7%1.2%0.3 $1.19 11/30/2024132,900 shares $172,770.00 -7.9%3.1%0.6 $1.30 11/15/2024144,300 shares $196,248.00 -35.2%3.4%0.5 $1.36 10/31/2024222,500 shares $349,325.00 -2.6%5.3%0.1 $1.57 Get the Latest News and Ratings for ALZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. 10/15/2024228,400 shares $381,428.00 +121.3%5.4%0.1 $1.67 9/30/2024103,200 shares $174,408.00 +47.9%3.0%0.1 $1.69 9/15/202469,800 shares $134,714.00 +2.8%2.4%0 $1.93 8/31/202467,900 shares $159,565.00 +162.2%10.7%0 $2.35 8/15/202425,900 shares $50,764.00 +50.6%4.1%0 $1.96 7/31/202417,200 shares $61,404.00 +126.3%2.1%1 $3.57 7/15/20247,600 shares $28,348.00 +153.3%1.3%0.7 $3.73 6/30/202429,900 shares $11,792.56 -68.6%0.5%0.4 $0.39 6/15/202495,100 shares $43,222.95 +65.7%1.8%1.2 $0.45 5/31/202457,400 shares $33,866.00 -30.1%1.1%0.9 $0.59 5/15/202482,100 shares $50,902.00 +264.9%1.7%1 $0.62 4/30/202422,500 shares $15,997.50 +55.2%0.5%0.3 $0.71 4/15/202414,500 shares $10,745.23 -68.0%0.3%0.3 $0.74 3/31/202445,300 shares $45,300.00 -11.5%0.9%0.8 $1.00 3/15/202451,200 shares $47,616.00 +13.0%1.0%0.9 $0.93 2/29/202445,300 shares $40,770.00 +2.5%0.9%0.7 $0.90 2/15/202444,200 shares $39,019.76 +4.5%0.9%0.8 $0.88 1/31/202442,300 shares $36,378.00 -41.5%0.9%0.3 $0.86 1/15/202472,300 shares $70,449.12 -2.8%1.9%0.5 $0.97 12/31/202374,400 shares $66,216.00 -43.5%2.1%0.6 $0.89 12/15/2023131,700 shares $131,700.00 -29.5%3.7%1 $1.00 11/30/2023186,900 shares $226,149.00 +379.2%5.7%1.6 $1.21 11/15/202339,000 shares $58,500.00 -18.2%1.2%0.4 $1.50 10/31/202347,700 shares $1.25 million -92.1%1.5%2.3 $26.26 10/15/2023602,000 shares $124,012.00 +30.0%1.2%2.8 $0.21 9/30/2023463,200 shares $109,778.40 +82.8%1.0%2.2 $0.24 9/15/2023253,400 shares $60,816.00 +17.3%0.5%1.3 $0.24 8/31/2023216,000 shares $56,635.20 -60.7%0.4%1.2 $0.26 8/15/2023549,900 shares $169,919.10 +8.9%1.2%2.8 $0.31 7/31/2023505,200 shares $228,855.60 +2.6%1.1%3 $0.45A $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOW (Ad)Expert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legend (with 255 winners to his name) has just predicted a dramatic - and completely unexpected - stock market rebound... as a $6.9 trillion cash tsunami floods back into stocks. He just shared the name of one stock which could potentially surge 300% or higher, free of charge.While it's online, get the facts - and his #1 stock right here. 7/15/2023492,500 shares $247,235.00 +4.0%1.1%3.1 $0.50 6/30/2023473,700 shares $241,587.00 +13.0%1.1%2.9 $0.51 6/15/2023419,400 shares $285,192.00 -44.9%0.9%2.5 $0.68 5/31/2023761,400 shares $552,928.68 +44.0%1.7%4.2 $0.73 5/15/2023528,600 shares $274,713.42 -11.1%1.2%3.2 $0.52 4/30/2023594,400 shares $325,315.12 -8.6%1.3%3.5 $0.55 4/15/2023650,500 shares $382,038.65 +10.9%1.4%3.4 $0.59 3/31/2023586,500 shares $249,262.50 -18.2%1.3%2.9 $0.43 3/15/2023717,000 shares $343,729.80 -0.4%1.6%2.4 $0.48 2/28/2023719,600 shares $386,353.24 +5.1%1.6%2.4 $0.54 2/15/2023685,000 shares $401,478.50 -31.1%1.5%2.2 $0.59 1/31/2023994,100 shares $659,784.17 +11.2%2.2%2.8 $0.66 1/15/2023893,700 shares $529,964.10 -44.8%2.0%2.5 $0.59 12/30/20221,620,000 shares $915,138.00 +3.2%4.5%4.4 $0.56 12/15/20221,570,000 shares $1.40 million -7.7%4.4%3.6 $0.89 11/30/20221,700,000 shares $1.96 million -20.6%5.8%3.3 $1.15 11/15/20222,140,000 shares $2.40 million +27.4%7.3%4 $1.12 10/31/20221,680,000 shares $1.97 million -11.1%5.4%2.9 $1.17 10/15/20221,890,000 shares $1.98 million -34.2%5.5%3.1 $1.05 9/30/20222,870,000 shares $3.42 million +221.9%8.4%4.8 $1.19 9/15/2022891,700 shares $1.11 million -33.0%2.6%1.9 $1.24 8/31/20221,330,000 shares $1.20 million +112.9%3.9%3.7 $0.91 8/15/2022624,800 shares $649,792.00 -40.5%1.8%1.6 $1.04 7/31/20221,050,000 shares $933,555.00 -10.3%3.4%2.9 $0.89 7/15/20221,170,000 shares $1.09 million +17.2%4.0%2.3 $0.93 6/30/2022998,700 shares $863,276.28 -4.9%3.5%1.4 $0.86 6/15/20221,050,000 shares $888,300.00 -37.9%3.6%1.2 $0.85 5/31/20221,690,000 shares $1.59 million +79.0%5.8%1.4 $0.94 5/15/2022943,900 shares $884,811.86 -41.0%2.4%0.7 $0.94 4/30/20221,600,000 shares $1.63 million +28.0%4.0%1.3 $1.02 4/15/20221,250,000 shares $1.30 million +51.0%3.2%1 $1.04 3/31/2022827,900 shares $1.02 million +83.2%2.1%0.6 $1.23 3/15/2022452,000 shares $411,320.00 -11.1%1.2%0.3 $0.91 2/28/2022508,400 shares $594,828.00 +2.1%1.3%0.2 $1.17 2/15/2022497,900 shares $687,102.00 -22.1%1.3%0.1 $1.38 1/31/2022638,900 shares $977,517.00 -73.0%1.7%0.2 $1.53 1/15/20222,370,000 shares $4.24 million +13.4%5.8%0.4 $1.79 12/31/20212,090,000 shares $3.97 million -10.3%5.2%0.3 $1.90 12/15/20212,330,000 shares $6.03 million +37.9%5.8%0.3 $2.59 11/30/20211,690,000 shares $3.62 million -39.4%4.3%0.3 $2.14 11/15/20212,790,000 shares $6.39 million +335.1%7.1%0.5 $2.29 10/29/2021641,200 shares $1.37 million +1.6%1.6%0.1 $2.14 10/15/2021631,400 shares $1.51 million +126.2%1.6%0.3 $2.39 9/30/2021279,100 shares $859,628.00 -50.5%0.7%0.1 $3.08 9/15/2021563,700 shares $1.48 million +8.3%1.5%0.3 $2.63 8/31/2021520,700 shares $1.59 million +281.2%1.4%0.2 $3.06 8/13/2021136,600 shares $475,368.00 No Change0.4%0.1 $3.48 ALZN Short Interest - Frequently Asked Questions What is Alzamend Neuro's current short interest? Short interest is the volume of Alzamend Neuro shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 120,900 shares of ALZN short. 1.91% of Alzamend Neuro's shares are currently sold short. Learn More on Alzamend Neuro's current short interest. Which institutional investors are shorting Alzamend Neuro? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Alzamend Neuro: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Alzamend Neuro? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.91% of Alzamend Neuro's floating shares are currently sold short. Is Alzamend Neuro's short interest increasing or decreasing? Alzamend Neuro saw a decline in short interest during the month of March. As of March 15th, there was short interest totaling 120,900 shares, a decline of 47.0% from the previous total of 228,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Alzamend Neuro's float size? Alzamend Neuro currently has issued a total of 6,597,000 shares. Some of Alzamend Neuro's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Alzamend Neuro currently has a public float of 6,320,000 shares. How does Alzamend Neuro's short interest compare to its competitors? 1.91% of Alzamend Neuro's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Alzamend Neuro: Cara Therapeutics, Inc. (1.93%), Allakos Inc. (2.23%), Cyclo Therapeutics, Inc. (3.55%), Chemomab Therapeutics Ltd. (1.63%), Natural Alternatives International, Inc. (0.09%), Lisata Therapeutics, Inc. (0.47%), BioVie Inc. (7.06%), Eagle Pharmaceuticals, Inc. (2.90%), Lakeshore Biopharma Co., Ltd. (0.22%), Lipocine Inc. (1.60%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Alzamend Neuro stock? Short selling ALZN is an investing strategy that aims to generate trading profit from Alzamend Neuro as its price is falling. ALZN shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Alzamend Neuro? A short squeeze for Alzamend Neuro occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALZN, which in turn drives the price of the stock up even further. How often is Alzamend Neuro's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALZN, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies Cara Therapeutics Short Interest Data Allakos Short Interest Data Cyclo Therapeutics Short Interest Data Chemomab Therapeutics Short Interest Data Natural Alternatives International Short Interest Data Lisata Therapeutics Short Interest Data BioVie Short Interest Data Eagle Pharmaceuticals Short Interest Data Lakeshore Biopharma Short Interest Data Lipocine Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALZN) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alzamend Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alzamend Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALZN Stock Free ALZN Stock Alerts